Linscott Walt Addison (CIK 0001648585)

Latest company ownership

Role: Chief Business Officer
Shares held
75,000
Last filed at
Jan 23, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 7, 2022 Sep 9, 2022 Indaptus Therapeutics, Inc. Chief Business Officer Buy 90.0 +150 100.00% $393